daratumumab and dexamethasone in the treatment of patients with myeloma and severe renal impairment
Published 2 years ago • 553 plays • Length 1:22Download video MP4
Download video MP3
Similar videos
-
2:30
daratumumab and isatuximab in the treatment of multiple myeloma
-
1:23
daratumumab, bortezomib & dexamethasone at first relapse: real-world study in patients with myeloma
-
1:55
dare: dara for r/r myeloma with renal impairment
-
3:57
daratumumab in the treatment of mm with high-risk cytogenetics
-
1:37
daratumumab vs isatuximab in the treatment of multiple myeloma
-
1:51
darazadex: a phase ii trial of daratumumab plus azacitidine and dexamethasone in r/r myeloma
-
13:43
darzalex® iv (daratumumab) mechanism of action for multiple myeloma
-
49:38
off-the-shelf immune drug for aggressive multiple myeloma: teclistamab
-
7:32
long-term efficacy of daratumumab-based regimen in multiple myeloma
-
2:13
daratumumab in the treatment of multiple myeloma
-
1:14
insights into the management of mds/mpn overlap syndromes & advice for clinicians
-
2:21
the role of daratumumab in the treatment of myeloma and insights into the maia trial
-
1:37
dpd against dvd for daratumumab-naïve patients with r/r multiple myeloma
-
1:58
treatment options for patients with multiple myeloma who are resistant to daratumumab
-
1:44
trimm-2: talquetamab daratumumab in patients with r/r multiple myeloma
-
2:36
approaching a myeloma population becoming increasingly resistant to daratumumab
-
0:54
the experience of single-agent daratumumab for r/r myeloma in india
-
5:07
daratumumab in the management of al amyloidosis
-
0:52
the future of daratumumab in multiple myeloma
-
4:01
choosing between isatuximab & daratumumab in multiple myeloma
-
1:01
car-t: myeloma toxicities